Liquidia Corp $LQDA

Recent News (5)

• Liquidia Corporation’s (LQDA) Yutrepia Launch Continues to Outpace the Expectations Yahoo Finance · 03 Sep 2026 Liquidia Corporation’s (LQDA) Yutrepia Launch Continues to Outpace the Expectations
• FDA Grants Fast Track Designation to YUTREPIA® for the Treatment of Raynaud's Phenomenon Associated with Systemic Sclerosis GlobeNewswire · 03 Sep 2026 Liquidia (Nasdaq: LQDA): FDA grants Fast Track designation to YUTREPIA for systemic sclerosis-associated Raynaud's phenomenon; Phase 2a study in Q4 2026
• Liquidia to Present Posters at the European Respiratory Society (ERS) 2026 Congress GlobeNewswire · 02 Sep 2026 MORRISVILLE, N.C., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challe…
• Liquidia Corporation to Participate in Wells Fargo Annual Healthcare Conference GlobeNewswire · 01 Sep 2026 MORRISVILLE, N.C., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced that Michael Kaseta, Chief Operating Officer and Chief Financial Officer, and Jason Adair, C…
• Liquidia Corporation Stock 12‑Month Price Target Raised to $86.5, Implies 2% Downside TradingView · 12 Aug 2026 Liquidia Corporation Stock 12‑Month Price Target Raised to $86.5, Implies 2% Downside  TradingView